Search
for
Sort by
Research 961–990 of 1000+
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Ann Robinson’s research reviews —12 May 2022
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Emerging treatments in alopecia
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part II Systemic Treatment
- Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib
- Review of modern methods of treating vitiligo
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- Tofacitinib in the Management of Alopecia Universalis
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Successful Treatment of Canities Subita with Baricitinib
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Deuruxolitinib for Alopecia Areata.
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- Alopecia areata: recognition, diagnosis and management
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES